Thermo Fisher Scientific Inc/ US8835561023 /
9/27/2023 9:59:59 PM | Chg. -3.31 | Volume | Bid- | Ask- | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
498.25USD | -0.66% | 70,312 Turnover: 35.03 mill. |
-Bid Size: - | -Ask Size: - | 192.31 bill.USD | 0.24% | 28.07 |
GlobeNewswire
3/10/2022
Oncocyte Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Corporate Update
GlobeNewswire
2/22/2022
Norton Rose Fulbright adds cutting-edge technology and life sciences team in San Francisco, includin...
GlobeNewswire
1/20/2022
The Valens Company to Participate in KCSA Cannabis Virtual Investor Conference
GlobeNewswire
1/18/2022
Oncocyte Announces Development and Co-Marketing Agreement with Thermo Fisher Scientific to Expand Ac...
GlobeNewswire
1/13/2022
PacBio Names Lara Toerien as Vice President and General Manager for the Americas
GlobeNewswire
1/6/2022
Mass General Brigham and Bank of America Announce Partnership for World Medical Innovation Forum
GlobeNewswire
1/5/2022
Berkeley Lights Announces CEO Transition and Preliminary Full Year 2021 Financial Update
GlobeNewswire
12/7/2021
Avid Bioservices Reports Financial Results for Second Quarter Ended October 31, 2021 and Recent Deve...
GlobeNewswire
11/15/2021
The Consortium for Top-Down Proteomics Launches the Human Proteoform Project
GlobeNewswire
10/29/2021
Leader in Corporate Development and Strategy Joins Mesa Labs Board of Directors
GlobeNewswire
9/30/2021
Pacira Announces Commercial Production Underway with Enhanced EXPAREL Manufacturing Process at Swind...
GlobeNewswire
9/29/2021
The Consortium for Top-Down Proteomics Launches a New Initiative to Develop the Human Proteoform Atl...